Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1979-01-17
1980-05-27
Moyer, Donald B.
Drug, bio-affecting and body treating compositions
Lymphokine
424126, 424164, 424175, 424249, A61K 3178, A01N 922, A61K 3153, A01N 900
Patent
active
042050650
ABSTRACT:
A novel composition of matter comprising a color-inhibiting additive, such as sodium bisulfite, and cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride or the cis-, trans- mixtures of 1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride, is a non-yellowing antimicrobial formulation suitable for the preservation of aqueous organic mixtures such as emulsions, dispersions, latexes and solutions. The color-inhibiting agent may be added as a solid or as an aqueous solution wherein the weight ratio of adamantane to additive is from about 1:0.01 to about 1:4.
REFERENCES:
patent: 3532657 (1970-10-01), Dick et al.
patent: 3766063 (1973-10-01), Blankenhorn
patent: 3908009 (1975-09-01), Polemenakos et al.
McCrary Avis L.
Wilson David A.
Hill Joyce P.
Moyer Donald B.
The Dow Chemical Company
LandOfFree
Non-yellowing compositions containing hexamethylenetetramine 1,3 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non-yellowing compositions containing hexamethylenetetramine 1,3, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-yellowing compositions containing hexamethylenetetramine 1,3 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1119727